Abbreviations used
FVC: Forced vital capacity GALA II: Gene-Environments and Admixture in Latino Asthmatics NHLBI: National Heart, Lung, and Blood Institute OR: Odds ratio SAGE II: Study of African Americans, Asthma, Genes, & Environments SHS: Secondhand smoke significantly affects quality of life and incurs substantial medical expenses and opportunity costs in missed days of work and school and premature deaths estimated at $56 billion in the United States in 2007. 13, 14 Among patients with asthma, SHS exposure is a risk factor for asthma exacerbations and the development of severe asthma. 15, 16 Therefore avoidance of SHS exposure is an important component of asthma prevention and control.
Although extensive research has demonstrated the effect of smoking on asthma risk in young children, the clinical effect and relative contribution of in utero smoking and current SHS exposure on asthma control is poorly documented, and there is a paucity of research involving minority populations. 6, 17 The objective of the current study was to investigate the contribution of in utero smoking and current SHS exposure toward poor asthma control among 2481 Latino and black children.
METHODS

Study design and recruitment
Subjects were recruited from the Study of African Americans, Asthma, Genes, & Environments (SAGE II) and the Gene-Environments and Admixture in Latino Asthmatics (GALA II) study. Both studies began in 2008 and are parallel, ongoing case-control studies with similar protocols and questionnaires. Subjects are recruited from 5 urban study centers across the mainland United States and Puerto Rico (see Table E1 in this article's Online Repository at www.jacionline.org). Target sample sizes (cases and control subjects) for GALA II and SAGE II are 4000 and 2000 subjects, respectively. Subjects recruited into the GALA II and SAGE II studies were 8 to 21 years old with physician-diagnosed asthma and no history of other lung or chronic illnesses; active smokers were excluded. Parents and grandparents self-identified as Latino (GALA II) or black (SAGE II); self-identification of race/ethnicity was required of study participants. The study population for the current analysis was limited to children 8 to 17 years old with no history of smoking, representing 1858 cases from GALA II and 623 cases from SAGE II who were recruited through November 2011. Inclusion/exclusion criteria are detailed in Table E2 (available in this article's Online Repository at www.jacionline.org).
We ascertained demographic, environmental, and medical histories using in-person questionnaires with the children's parents/caretakers; selected questions are reproduced in Table E3 (available in this article's Online Repository at www.jacionline.org). The primary exposures for our analysis were in utero smoking and current SHS exposure. Current SHS exposure was most correlated with exposure occurring after age 6 years (Pearson r 5 0.55) and least with exposure in the first 2 years of life (Pearson r 5 0.37). Additionally, postnatal SHS exposure was most correlated with exposure at adjacent time points (eg, correlation between ages 0-2 and ages 3-6 years 5 0.75). Our final regression models therefore included postnatal SHS terms for ages 0 to 2 years and current SHS exposure to maximize exposure assessment and minimize multicollinearity. Race/ethnicity was categorized as follows: black, Mexican, Puerto Rican, and other Latino (Latino subgroups representing <10% of the study population). Socioeconomic status indicators included family income and the child's father's employment status.
To assess and account for asthma control medications children might have been using, we asked subjects' parents to identify their child's asthma control medication or medications from a picture library of asthma control medications. We grouped their responses into one of 4 categories: none, monotherapy, combination therapy, and oral corticosteroids. Children using either leukotriene modifiers or inhaled corticosteroids were classified as receiving monotherapy, combination therapy was used to describe the concomitant use of 2 or more medications (except for oral corticosteroids), and children using oral corticosteroids were classified into a separate category.
Clinical outcomes
The NHLBI measure of asthma control is a composite score and an accepted standard for measuring asthma control. 12 We used NHLBI-defined criteria to classify children with asthma as having controlled, partially controlled, or uncontrolled disease (see Table E4 in this article's Online Repository at www.jacionline.org for a more detailed description of criteria and cut points). The component measures of asthma control, assessed retrospectively over the week preceding subject recruitment and interview, included daytime and nighttime symptoms, asthma-related limitation of activities, use of rescue medication, and spirometric lung function measures. An FEV 1 /forced vital capacity (FVC) ratio of less than 85% was used as our lung function criterion because it is more sensitive than FEV 1 in children. 12 Estimates using either criterion produced similar results. Secondary outcomes included early-onset (<4 years of age) asthma, presence of daytime/nocturnal symptoms, asthmarelated activity limitations, FEV 1 less than 80% of predicted value, and an FEV 1 /FVC ratio of less than 85%.
Statistical analysis
Only children with asthma were included in the analyses. Statistical methods are detailed in the Methods section in this article's Online Repository at www.jacionline.org. After verifying the proportional odds assumption, we used ordinal logistic regression to calculate odds ratios (ORs) and 95% CIs to estimate the association of in utero smoking and current SHS with asthma control while controlling for eczema, use of asthma control medication, exposure to home indoor allergens, IgE level, socioeconomic status, race/ethnicity, age, sex, and study center. To account for potential differences between mainland and island Puerto Rican subjects, we classified Puerto Rican subjects based on their recruitment site (ie, mainland vs island Puerto Ricans). Because our outcome variable (asthma control) was a 3-level ordinal variable (controlled asthma, partially controlled asthma, and uncontrolled asthma), we used ordinal logistic regression to compare the odds of exposure between one level of asthma control and a worse level of asthma control (ie, a single OR was used to compare controlled vs partially controlled asthma or partially controlled vs uncontrolled asthma). All analyses were conducted with SAS version 9.2 software (SAS Institute, Inc, Cary, NC).
This study was approved by the institutional review boards at each study center. All subjects (or their parents) provided written informed consent.
RESULTS
Characteristics of children with asthma are presented in Table I . Nearly half of the GALA II subjects were Puerto Rican (47.2%), followed by Mexican (31.8%) and other Latino ethnicities (21.0%). All SAGE II subjects were non-Hispanic black. In utero smoke exposure during the first trimester was slightly higher among Puerto Ricans (5.8%) compared with Mexican (3.2%) and other Latino (3.3%) children and substantially higher among black children (17.7%). Smoking cessation during pregnancy among Puerto Rican and black mothers was uncommon (65% and 71%, respectively, reported smoking during their third trimester; see Fig E1 in this article's Online Repository at www. jacionline.org). In contrast, smoking cessation during pregnancy was greater for Mexican mothers and other Latino mothers (72% and 54%, respectively, stopped smoking by the second trimester), and more mothers continued to stop smoking as pregnancy progressed (83% of Mexican and 67% of other Latino mothers had stopped smoking by their third trimester). We examined potential interactions between race/ethnicity with in utero and current smoking but did not find them to be significant.
Asthma control
Poor asthma control was positively associated with IgE levels. Compared with Mexican children, asthma control was worse for black children (OR, 2.3; 95% CI, 1.6-3.2) but not significantly different from that seen in Puerto Rican (OR, 1.3; 95% CI, 0.8-2.1) and other Latino (OR, 1.2; 95% CI, 0.9-1.7) children. After accounting for these factors, in utero smoking remained a significant predictor of poor asthma control. Children with poor asthma control were more likely to have been exposed to in utero smoking (OR, 1.5; 95% CI, 1.1-2.1; Table II) , and a greater percentage of children were exposed to in utero smoking with worsening asthma control (Fig 1) . The association between poor asthma control and in utero smoking was greater among Latino children (OR, 1.7; 95% CI, 1.1-2.7) than among black children (OR, 1.2; 95% CI, 0.7-1.8), although the latter group might have been underpowered. The odds of poor asthma control were greater among children exposed to in utero smoking only during the first trimester (OR, 2.2; 95% CI, 1.3-3.7) compared with children exposed for all 3 trimesters (OR, 1.2; 95% CI, 0.7-1.8), but the estimates did not suggest a significant difference between children exposed only during the first trimester versus children exposed for all 3 trimesters (P heterogeneity 5 .09). We did not find significant evidence of an independent association between exposure to current household smokers and poor asthma control (OR, 1.1), but the majority of the 95% CI (0.9-1.3) suggested that current SHS exposure was associated with worse asthma control. In utero smoking was also independently associated with secondary asthma outcomes: early-onset asthma, daytime symptoms, and limitation of activities (Table III) .
The independent and joint contributions of in utero smoking and current SHS exposure on asthma control are summarized in Table IV . Compared with children with neither in utero smoking nor current SHS exposure, the association between poor asthma control among children with both in utero smoking and current SHS exposure was 1.3 (95% CI, 0.8-2.0), which was not substantially different from estimates for children with only current SHS exposure (OR, 1.1; 95% CI, 0.9-1.4) or in utero smoking (OR, 1.8; 95% CI, 1.2-2.8), although the only statistically significant OR was for children exposed only to in utero smoking.
DISCUSSION
The association between SHS and asthma control has previously been investigated, but the independent effects of in utero smoking and current SHS exposure on asthma control have not been well documented, particularly among minority populations. In our sample of 2481 Latino and black children with asthma, we demonstrate that in utero smoking negatively affects asthma control. Compared with children with controlled asthma, in utero smoking is 50% more common among children with poor asthma control independent of other risk factors for poorly controlled asthma.
Smoking during pregnancy is particularly insidious not only for harming the developing fetus but also for its effects manifested in later life. 6 In our study children with poor asthma control were more likely to have been exposed to tobacco smoke while they were in utero, suggesting that prenatal exposures have lingering effects more than 8 years after exposure (children in our study were 8-17 years old). Potential mechanisms might include epigenetic (eg, methylation) events and morphologic changes in utero. There is mounting evidence, for example, that prenatal exposure to cigarette smoke results in DNA methylation (which plays a role in gene expression) that has been measured at birth, 18 childhood, 19, 20 and adulthood, 21 suggesting that in utero exposure can lead to modifications in DNA that persist long after the exposure has occurred. In utero exposure to tobacco smoke is also associated with aberrant development of the fetal lung 22, 23 and decreased lung function. 5, 24, 25 Given that the majority of lung development occurs during the first trimester and the observation that nicotine accelerates lung branching morphogenesis during this period, 23 in utero smoking might potentially lead to poor asthma control through dysynaptic lung development (ie, disproportionate growth) and subsequent obstructive lung disease. This potential mechanism is consistent with our finding that the association between poor asthma control and in utero smoking is stronger for children who were exposed during the first trimester (Table II) , although the reliability of trimester-specific estimates might be compromised by the low number of children exposed within a given trimester of pregnancy. The lack of a robust association between poor asthma control and current SHS exposure in our study is consistent with reports in the literature [26] [27] [28] [29] that the contribution of SHS is more prominent among younger children. Mannino et al, 26 for example, report that asthma prevalence in the Third National Health and Nutrition Examination Survey was associated with biomarker-determined tobacco smoke exposure among 4-to 6-year-olds but not among older children. A review of longitudinal studies of asthma incidence has also reported a stronger association with SHS among younger children than among older children. 28 Given the strong association between in utero smoking and poor asthma control, the low smoking cessation rates during pregnancy among Puerto Rican and black subjects present public health opportunities for targeted interventions. In our study sample 9% of subjects were exposed to in utero smoking. Assuming minimal bias and confounding in our effect estimates, 10% of children would have had better asthma control had they not been exposed to in utero smoking (see the Methods section in this article's Online Repository). This observation lends additional urgency to tobacco control efforts and supports the practice of inquiring about cigarette use and counseling smoking cessation at all clinical encounters. 30 Our results should be interpreted with an understanding of this study's strengths and limitations. Because asthma is known to be more prevalent among male subjects in young children and among female subjects in older children, sex and hormonal differences in our study population might have affected our results. We therefore re-examined the association between tobacco smoke exposure and asthma control for male and female subjects, performing separate analyses for subjects aged 8 to 11 and 12 to 17 years (see Table E5 in this article's Online Repository at www.jacionline.org). Although the ORs for older and younger male subjects were fairly similar, the association between in utero smoking and poor asthma control seemed stronger among younger female subjects (OR, 1.9; 95% CI, 0.9-4.2) than among older female subjects (OR, 1.3; 95% CI, 0.7-2.4; see Table E5 ). However, we did not see evidence of a sex-age interaction between in utero smoking and poor asthma control (interaction P 5 .94).
The absence of an interaction might be due to a lack of heterogeneity of the association or a lack of statistical power after stratifying the sample into age/sex strata. To maintain statistical power, we therefore reported the unstratified associations by using regression models that include variables to represent sex and age category (<12 vs > _12 years). Subjects were recruited as part of a clinic-based case-control study. Therefore our estimates of SHS should not be interpreted as prevalence or extrapolated to the general population. Because the current environment for some of our older participants might be very different from those in which they were raised, we included postnatal SHS exposure during participants' first 2 years of life. However, our method might still not have adequately accounted for a participant's history of exposure to tobacco smoke. Our assessment of current smoking was not confirmed by biomarker (eg, cotinine) measurement, and the retrospective design might have affected exposure estimates. For example, subjects might have underreported in utero smoking to provide socially desirable answers, which could have underestimated the effect. Alternatively, our estimates could have been inflated if recall of in utero smoking was overreported, although this type of upward bias appears to be uncommon when assessing smoking during pregnancy. [31] [32] [33] However, the proportion of in utero smoking in our study is consistent with national estimates, and the concordance between our observations with published data for similar measures suggests that our estimate of in utero smoking is accurate. 34, 35 Puerto Rican children in our study population were recruited from Puerto Rico, as well as from the mainland United States. We therefore re-examined the association between asthma control and tobacco smoke exposure after classifying Puerto Rican subjects based on their recruitment site, but we did not observe a distinguishable change in our measures of association. However, we acknowledge that our approach might not have adequately controlled for important differences between island-and mainland-recruited Puerto Rican children, posing potential challenges to our interpretation of results for this subgroup. Selection bias might have affected our study: because we used a case-control study design, we were unable to confirm the temporality between exposure to SHS and worsening of asthma control. Parents of children with poorly controlled asthma might be more likely not to smoke so as not to exacerbate their child's asthma. Thus we might have underestimated the strength of the association between poor asthma control and current SHS exposure, and a longitudinal study comparing the effects between in utero and current SHS on asthma control (eg ,  Table IV ) might produce different estimates. Self-report could ORs for asthma control are adjusted for eczema, use of asthma control medication, exposure to home indoor allergens, SHS exposure during the first 2 years of life, IgE level, socioeconomic status, race/ethnicity, age, sex, and study center. P heterogeneity 5 .21 for in utero smoking and .24 for current SHS. *Not calculated for exposure during first 2 trimesters given that only 17 subjects were exposed during this period. have influenced our outcome measures, but the bias is unlikely to be severe. The associations we found are robust and remained significant after controlling for SHS exposure at other time points and from other sources. Additionally, our estimates for poor asthma control by race/ethnicity are consistent with national vital statistics data, lending convergent validity to the observation that asthma mortality is lowest in Mexican subjects and highest in Puerto Rican and black subjects. 36 To our knowledge, we have conducted the largest investigation of the association between in utero smoking and current SHS exposure with asthma control among minority children. Our estimates are unlikely to be highly confounded given our use of a detailed questionnaire, which allowed us to control for potential confounding between tobacco smoke exposure and asthma control. Our study's large size helped produce more precise estimates. We also measured tobacco smoke exposure from multiple time points and sources to reduce the influence of residual confounding. Our study population was composed of young Latino and black subjects of predominantly low SES. Consequently, our results generalize toward populations disproportionately affected by asthma. Furthermore, our focus on Latino and black subjects has significant public health implications given the discrepancy in asthma burden relative to the lack of minority representation in clinical and basic asthma research.
In conclusion, we demonstrate that tobacco smoke exposure while in utero (a relatively short duration) is associated with poor asthma control, suggesting that prenatal exposures have lingering effects at least 8 years after exposure. Asthma is a lifelong disease negatively affected by cigarette smoke. Preventing cigarette smoke exposure during pregnancy will have important implications for improving asthma control and reducing health disparities. Activities, Activities limited by asthma in past week; early onset, asthma onset at less than 4 years; nocturnal, woken by asthma in past week; symptoms, wheeze or shortness of breath in past week. *ORs represent multivariable associations between a given characteristic and secondary outcomes adjusted for the other covariates in the table, as well as for study center. ORs are adjusted for eczema status, use of asthma control medication, log-transformed serum IgE level, father's employment status, annual income, presence of mold or cockroaches in home, SHS exposure during first 2 years of life, race/ethnicity, age, sex, and study center.
METHODS
Statistical analysis
We used the x 2 and t statistics to determine significant bivariate associations of all potential covariates with asthma control. A 3-level ordinal variable represented the number of smokers currently living with the child: 0 smokers, 1 smoker, and 2 or more smokers. Covariates were considered for inclusion in the final model if they were associated with asthma control (P < .2) to identify possible confounding variables. We also evaluated models specified through forward and backward selection, keeping in utero smoking, current SHS exposure, race/ethnicity, use of asthma control medication, and study center in all models. Both methods identified the same covariates: eczema, exposure to indoor allergens (mold, mildew, and cockroaches) at home in the past year, log-transformed IgE levels, and socioeconomic status. Potential interactions of covariates with in utero smoking and current SHS exposure were assessed by including their product term in regression models; significant interaction terms were included as covariates. All analyses were conducted with SAS version 9.2 software.
Calculation of attributable fraction
The attributable fraction was calculated by creating a counterfactual data set in which all subjects were unexposed for the predictor of interest (eg, in utero smoking) while preserving the original values for all other covariates. The same regression model that was used to fit the outcome of interest (ie, asthma control) was used on the counterfactual data set, specifying SAS to output the predicted probabilities for each subject. These probabilities were then summed over all subjects to derive the expected number of subjects with the outcome under the counterfactual scenario. The difference of this number from the observed number of subjects with the outcome was divided by the observed number to obtain the attributable fraction. We used the FEV 1 /FVC ratio as our lung function criterion instead of FEV 1 because the former is a more sensitive measure of control in children (NHLBI Third Expert Panel on the Management of Asthma. Guidelines for the diagnosis and management of asthma: full report 2007). We compared our estimates using both definitions and found that the results were similar when either criterion was used. ORs and 95% CIs represent the association between asthma control and either in utero smoking or current SHS exposure. ORs for asthma control are adjusted for eczema, use of asthma control medication, exposure to home indoor allergens, SHS exposure during the first 2 years of life, IgE level, socioeconomic status, race/ethnicity, and study center. P heterogeneity 5 .87 for in utero smoking and .66 for current SHS.
